Perspectives for Clinical Practice: The Latest Advances for HER2-positive Metastatic Breast Cancer
Host: William J. Gradishar MD, FASCO, FACP
Guest: Peter Schmid, FRCP, MD, PhD
This activity will enhance knowledge and competence in the management of HER2-positive breast cancer. Dr. William Gradishar and Dr. Peter Schmid engage in a lively discussion regarding the latest clinical data supporting novel investigational and approved therapies for the treatment of HER2-positive metastatic breast cancer. They also review strategies to manage adverse events associated with these therapies.